Tag Archives | Addyi

Addyi FDA Approval: Premature Approbation?

On August 18, 2015, the FDA approved Addyi (flibanserin), a drug to treat “acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.” The FDA defines HSDD as “low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the […]

Read full story · Comments { 0 }

Tags: , , , , , , , , , ,